REVIVA PHARMACEUTICALS HOLDI (RVPH)

US76152G1004 - Common Stock

2.98  -0.04 (-1.32%)

Buy % Consensus

82

ChartMill assigns a Buy % Consensus number of 82% to RVPH. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 16.93. This target is 468.19% above the current price.
RVPH was analyzed by 11 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about RVPH.
In the previous month the buy percentage consensus was at a similar level.
RVPH was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 2.9812.1217.3416.9321.00 - 306.71% 481.88% 468.19% 604.70%
Up and Down Grades
Date Firm Action Rating
2024-04-22 HC Wainwright & Co. Reiterate Buy -> Buy
2024-04-16 Benchmark Reiterate Speculative Buy -> Speculative Buy
2024-03-25 HC Wainwright & Co. Reiterate Buy -> Buy
2024-02-20 HC Wainwright & Co. Reiterate Buy -> Buy
2023-12-26 HC Wainwright & Co. Reiterate Buy -> Buy
2023-10-31 HC Wainwright & Co. Maintains Buy -> Buy
2023-10-30 Roth MKM Reiterate Buy -> Buy
2023-09-20 Roth MKM Initiate Buy
2023-08-16 HC Wainwright & Co. Reiterate Buy -> Buy
2023-06-26 HC Wainwright & Co. Reiterate Buy -> Buy
2023-06-08 Benchmark Initiate Speculative Buy
2023-05-08 HC Wainwright & Co. Reiterate Buy
2023-05-03 Maxim Group Maintains Buy
2023-04-04 HC Wainwright & Co. Reiterate Buy
2023-01-25 HC Wainwright & Co. Reiterate Buy
2022-11-01 Alliance Global Partners Initiate Buy
2022-11-01 Maxim Group Maintains Buy
2022-01-24 HC Wainwright & Co. Initiate Buy
2021-07-26 Maxim Group Initiate Buy